BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 20862669)

  • 1. Factors affecting power of tests for multiple binary outcomes.
    Mascha EJ; Imrey PB
    Stat Med; 2010 Dec; 29(28):2890-904. PubMed ID: 20862669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of odds ratio or relative risk to measure a treatment effect in clinical trials with multiple correlated binary outcomes: data from the NINDS t-PA stroke trial.
    Lu M; Tilley BC;
    Stat Med; 2001 Jul; 20(13):1891-901. PubMed ID: 11427947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating treatment efficacy over time: a logistic regression model for binary longitudinal outcomes.
    Choi L; Dominici F; Zeger SL; Ouyang P
    Stat Med; 2005 Sep; 24(18):2789-805. PubMed ID: 16134133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the statistical power of different methods for the analysis of cluster randomization trials with binary outcomes.
    Austin PC
    Stat Med; 2007 Aug; 26(19):3550-65. PubMed ID: 17238238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global tests for multiple binary outcomes.
    Lefkopoulou M; Ryan L
    Biometrics; 1993 Dec; 49(4):975-88. PubMed ID: 8117908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A likelihood approach to analyzing clinical trial data when treatments favor different outcomes.
    McClure LA; Brown MB
    Contemp Clin Trials; 2006 Aug; 27(4):340-52. PubMed ID: 16426899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
    National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
    Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the effect of treatment in experiments with correlated binary outcomes.
    Zucker D; Wittes J
    Biometrics; 1992 Sep; 48(3):695-709. PubMed ID: 1420835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simulation study of odds ratio estimation for binary outcomes from cluster randomized trials.
    Ukoumunne OC; Carlin JB; Gulliford MC
    Stat Med; 2007 Aug; 26(18):3415-28. PubMed ID: 17154246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
    Hertzberg V; Ingall T; O'Fallon W; Asplund K; Goldfrank L; Louis T; Christianson T
    Clin Trials; 2008; 5(4):308-15. PubMed ID: 18697845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
    Shiotsuki H; Ogushi Y; Fushimi K; Kobayashi S;
    Tokai J Exp Clin Med; 2005 Apr; 30(1):49-62. PubMed ID: 15952299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arcsine test for publication bias in meta-analyses with binary outcomes.
    Rücker G; Schwarzer G; Carpenter J
    Stat Med; 2008 Feb; 27(5):746-63. PubMed ID: 17592831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke.
    Saver JL
    Arch Neurol; 2004 Jul; 61(7):1066-70. PubMed ID: 15262737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond subgroup analysis: improving the clinical interpretation of treatment effects in stroke research.
    Lu M; Lyden PD; Brott TG; Hamilton S; Broderick JP; Grotta JC
    J Neurosci Methods; 2005 Apr; 143(2):209-16. PubMed ID: 15814153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A generalized estimating equation approach for modeling random length binary vector data.
    Albert PS; Follmann DA; Barnhart HX
    Biometrics; 1997 Sep; 53(3):1116-24. PubMed ID: 9290230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A SAS macro for the analysis of multivariate longitudinal binary outcomes.
    Shelton BJ; Gilbert GH; Liu B; Fisher M
    Comput Methods Programs Biomed; 2004 Nov; 76(2):163-75. PubMed ID: 15451165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.
    Varadhan R; Weiss CO; Segal JB; Wu AW; Scharfstein D; Boyd C
    Med Care; 2010 Jun; 48(6 Suppl):S96-105. PubMed ID: 20473207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal and repeated cross-sectional cluster-randomization designs using mixed effects regression for binary outcomes: bias and coverage of frequentist and Bayesian methods.
    Localio AR; Berlin JA; Have TR
    Stat Med; 2006 Aug; 25(16):2720-36. PubMed ID: 16345043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating treatment effect heterogeneity for binary outcomes via Dirichlet multinomial constraints.
    Masch EJ; Albert JM
    Biom J; 2007 Jun; 49(3):378-93. PubMed ID: 17623343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.